DOCSLIB.ORG

Control of Embryonic Stem Cell Self-Renewal and Differentiation Via Coordinated Alternative Splicing and Translation of YY2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Control of Embryonic Stem Cell Self-Renewal and Differentiation Via Coordinated Alternative Splicing and Translation of YY2 Control of embryonic stem cell self-renewal and differentiation via coordinated alternative splicing and translation of YY2 Soroush Tahmasebia,b,1, Seyed Mehdi Jafarnejada,b,1, Ingrid S. Tama,b, Thomas Gonatopoulos-Pournatzisc, Edna Matta-Camachoa,b, Yoshinori Tsukumoa,b,2, Akiko Yanagiyaa,b, Wencheng Lid, Yaser Atlasie, Maxime Caronf,g, Ulrich Braunschweigc, Dana Pearla,b, Arkady Khoutorskyh, Christos G. Gkogkasi, Robert Nadonf,g, Guillaume Bourquef,g, Xiang-Jiao Yanga,b,j, Bin Tiand, Hendrik G. Stunnenberge, Yojiro Yamanakaa,f, Benjamin J. Blencowec,k, Vincent Giguèrea,b,j, and Nahum Sonenbergb,c,3 aGoodman Cancer Research Center, McGill University, Montreal, QC H3A 1A3, Canada; bDepartment of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; cDonnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada; dDepartment of Microbiology, Biochemistry, and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ 07103; eDepartment of Molecular Biology, Faculty of Science, Radboud University, Nijmegen, 6525GA, The Netherlands; fDepartment of Human Genetics, McGill University, Montreal, QC H3A 1A3, Canada; gMcGill University and Genome Quebec Innovation Centre, Montreal, QC H3A 0G1, Canada; hDepartment of Anesthesia, McGill University, Montreal, QC, H3G 1Y6, Canada; iPatrick Wild Centre, Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom; jDepartment of Medicine, McGill University Health Center, Montreal, QC H3A 1A3, Canada; and kDepartment of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2015. Contributed by Nahum Sonenberg, September 22, 2016 (sent for review August 15, 2016; reviewed by George Q. Daley and Maurice S. Swanson) Translational control of gene expression plays a key role during family of small molecular weight (15–20 kDa) translational inhibitors the early phases of embryonic development. Here we describe a (4E-BP1, -2, and -3 in mammals), that, when dephosphorylated, av- transcriptional regulator of mouse embryonic stem cells (mESCs), idly bind eIF4E and block its association with eIF4G to form the Yin-yang 2 (YY2), that is controlled by the translation inhibitors, eIF4F complex. Following phosphorylation by mTORC1, 4E-BPs Eukaryotic initiation factor 4E-binding proteins (4E-BPs). YY2 plays dissociate from eIF4E, allowing the formation of the eIF4F complex a critical role in regulating mESC functions through control of key and activation of translation (8, 10–12). 4E-BPs inhibit cap-dependent Oct4 pluripotency factors, including Octamer-binding protein 4 ( ) translation in embryonic and somatic stem cells (3, 4, 13, 14). Al- and Estrogen-related receptor-β (Esrrb). Importantly, overexpres- though eIF4E promotes cap-dependent translation of all cellular sion of YY2 directs the differentiation of mESCs into cardiovascular mRNAs, the translation of a subsetofmRNAs,whichgenerally lineages. We show that the splicing regulator Polypyrimidine tract- ′ binding protein 1 (PTBP1) promotes the retention of an intron in the contain a long and highly structured 5 -UTR, is strongly dependent “ ” 5′-UTR of Yy2 mRNA that confers sensitivity to 4E-BP–mediated on eIF4E (9, 15). These mRNAs are known as eIF4E-sensitive and translational suppression. Thus, we conclude that YY2 is a major regulator of mESC self-renewal and lineage commitment and docu- Significance ment a multilayer regulatory mechanism that controls its expression. Embryonic stem cells (ESCs) maintain a low translation rate; mRNA translation | 4E-BPs | PTBP | embryonic stem cell | YY2 therefore control of mRNA translation is critical for preserving their stemness. We identified a hitherto unstudied transcription tringent control of mRNA translation is critical during early factor, Yin-yang 2 (YY2), which is translationaly regulated and Sembryonic development, because relatively small changes in controls self-renewal and differentiation of mouse ESCs (mESCs). the expression of development-related genes can dramatically Although YY2 is essential for mESC self-renewal, increased YY2 affect the self-renewal and differentiation of stem cells. In fact, a expression directs differentiation of mESCs toward cardiovas- modest (twofold or less) increase or decrease in Octamer-binding cular lineages. Examination of the Yy2 5′-UTR revealed a multi- protein 4 (OCT4) or Sex-determining region Y (SRY)-box 2 layer regulatory mechanism through which YY2 expression is (SOX2) protein levels impairs ESC self-renewal and triggers dif- dictated by the combined actions of the splicing regulator, ferentiation (1, 2). mRNA translation, which is low in undiffer- Polypyrimidine tract-binding protein 1 (PTBP1), and the trans- entiated embryonic stem cells (ESCs) and multipotent somatic lation inhibitors, Eukaryotic initiation factor 4E-binding pro- stem cells (e.g., hematopoietic stem cells and skin stem cells), teins (4E-BPs). YY2 directly controls the expression of several increases significantly during differentiation (3–5). Importantly, pluripotency and development-related genes. This study de- genome-wide analysis of the transcriptome vs. proteome of ESCs scribes a synchronized network of alternative splicing and mRNA during the early stages of differentiation demonstrated that pro- translation in controlling self-renewal and differentiation. tein levels correlate poorly with mRNA levels (Pearson’s R < 0.4), underscoring the importance of posttranscriptional regulation in Author contributions: S.T., S.M.J., and N.S. designed research; S.T., S.M.J., I.S.T., T.G.-P., E.M.-C., Y.T., A.Y., W.L., D.P., A.K., X.-J.Y., and Y.Y. performed research; C.G.G. contrib- ESC differentiation (6). uted new reagents/analytic tools; S.T., S.M.J., I.S.T., T.G.-P., E.M.-C., Y.T., A.Y., W.L., Y.A., mRNA translation can be divided into three steps: initiation, M.C., U.B., R.N., G.B., B.T., H.G.S., Y.Y., B.J.B., and V.G. analyzed data; and S.T., S.M.J., and elongation, and termination. Translational control has been docu- N.S. wrote the paper. mented most extensively at the initiation step, at which ribosomes Reviewers: G.Q.D., Children’s Hospital Boston; and M.S.S., University of Florida. are recruited to the mRNA by the concerted action of Eukaryotic The authors declare no conflict of interest. translation initiation factors (eIFs) (7). Control of translation is 1S.T. and S.M.J. contributed equally to this article. – exerted mainly by two key protein complexes: eIF4F (eIF4E 2Present address: Division of Molecular Target and Gene Therapy Products, National In- Met eIF4G–eIF4A) and the ternary complex (eIF2–GTP–Met-tRNA i) stitute of Health Sciences, Setagaya-ku, Tokyo 158-8501, Japan. (7). The mammalian target of rapamycin complex 1 (mTORC1) 3To whom correspondence should be addressed. Email: [email protected]. controls the assembly of eIF4F through the phosphorylation of This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. eIF4E-binding proteins (4E-BPs) (8, 9). The 4E-BPs consist of a 1073/pnas.1615540113/-/DCSupplemental. 12360–12367 | PNAS | November 1, 2016 | vol. 113 | no. 44 www.pnas.org/cgi/doi/10.1073/pnas.1615540113 Downloaded by guest on September 30, 2021 encode proteins that control fundamental cellular processes such as cell proliferation and survival (16). INAUGURAL ARTICLE We showed that 4E-BPs are required for reprogramming mouse embryonic fibroblasts (MEFs) to induced pluripotent stem cells (iPSCs) (17). In the current study, we describe a tightly coordi- nated network in mESCs whereby the expression of the Yin-yang 2 (YY2) transcription factor is controlled by the splicing regulator Polypyrimidine tract-binding protein 1 (PTBP1) and the 4E-BP translation inhibitors. Our data reveal that stringent regulation of YY2 expression by this network is critical for mESC self-renewal and lineage commitment. Results Transcriptome and Translatome Profiling of WT and 4E-BP1/2–Null mESCs. To investigate the role of 4E-BPs in mESCs, we first derived mESCs from WT and Eukaryotic translation initiation factor 4E- binding protein 1 (Eif4ebp1) and Eukaryotic translation initiation Fig. 1. The lack of 4E-BPs deregulates the expression of pluripotency factors factor 4E-binding protein 2 (Eif4ebp2) double-knockout (DKO) in mESCs. (A and B) The log2 abundanceofRFPs(A) and mRNA (RNA-Seq) (B) mice and then examined the eIF4F complex using a 7-methyl-GTP of transcripts that were included in Babel analysis are plotted for WT and 7 (m GTP)-agarose pull-down assay. The eIF4F amount was ele- Eif4ebp1 and Eif4ebp2 DKO mESCs. (C) Babel analysis of transcripts with a vated, as demonstrated by increased (∼10.6-fold) eIF4G1 pull-down significant change in RFPs independent of the corresponding change in mRNA in DKO mESCs (Fig. S1A). However, polysome profiling (Fig. S1B) abundance (black dots; FDR < 0.1). Triml2 and Trmt61b, respectively, are and [35S]methionine/cysteine-labeling assays (Fig. S1C) did not mRNAs with the highest and the lowest RFP ratios in DKO compared with WT detect a substantial difference in global mRNA translation between mESCs; FC, fold change. (D) Western blot analysis of NANOG expression in a WT and DKO mESCs. These data are consistent with previous WT mESC and in two independent DKO mESC clones (C1 and C2). Numbers indicate the ratio of NANOG expression in each clone to that in the WT mESC findings that the lack of 4E-BPs affects the
Load more

Recommended publications
  • Reinforcement of STAT3 Activity Reprogrammes Human Embryonic Stem Cells to Naive-Like Pluripotency
    ARTICLE Received 17 Apr 2014 | Accepted 2 Apr 2015 | Published 13 May 2015 DOI: 10.1038/ncomms8095 OPEN Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency Hongwei Chen1,2, Ire`ne Aksoy1,2,3, Fabrice Gonnot1,2, Pierre Osteil1,2, Maxime Aubry1,2, Claire Hamela1,2, Cloe´ Rognard1,2, Arnaud Hochard1,2, Sophie Voisin1,2,4, Emeline Fontaine1,2, Magali Mure1,2, Marielle Afanassieff1,2,4, Elouan Cleroux5, Sylvain Guibert5, Jiaxuan Chen3,Ce´line Vallot6, Herve´ Acloque7, Cle´mence Genthon7,Ce´cile Donnadieu7, John De Vos8,9, Damien Sanlaville10, Jean- Franc¸ois Gue´rin1,2, Michael Weber5, Lawrence W. Stanton3, Claire Rougeulle6, Bertrand Pain1,2,4, Pierre-Yves Bourillot1,2 & Pierre Savatier1,2 Leukemia inhibitory factor (LIF)/STAT3 signalling is a hallmark of naive pluripotency in rodent pluripotent stem cells (PSCs), whereas fibroblast growth factor (FGF)-2 and activin/nodal signalling is required to sustain self-renewal of human PSCs in a condition referred to as the primed state. It is unknown why LIF/STAT3 signalling alone fails to sustain pluripotency in human PSCs. Here we show that the forced expression of the hormone-dependent STAT3-ER (ER, ligand-binding domain of the human oestrogen receptor) in combination with 2i/LIF and tamoxifen allows human PSCs to escape from the primed state and enter a state char- acterized by the activation of STAT3 target genes and long-term self-renewal in FGF2- and feeder-free conditions. These cells acquire growth properties, a gene expression profile and an epigenetic landscape closer to those described in mouse naive PSCs.
    [Show full text]
  • Boosting the Cellular Potency of Embryonic Stem Cells by Spliceosome Targeting ✉ Wilfried A
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans RESEARCH HIGHLIGHT OPEN Boosting the cellular potency of embryonic stem cells by spliceosome targeting ✉ Wilfried A. Kues1 Signal Transduction and Targeted Therapy (2021) 6:324; https://doi.org/10.1038/s41392-021-00743-9 In recent work published in Cell, Shen et al.1 identified transfected ES cells with short interfering RNAs against different spliceosome inhibition in embryonic stem (ES) cells as a key spliceosome transcripts (the spliceosome consisted of 5 core and mechanism for the transition from pluri- to totipotency. Spliceo- several cofactor subunits, here 14 transcripts were targeted), some inhibition, achieved by RNA interference or the chemical respectively. Transient repression of 10 of the 14 splicing factors inhibitor pladienolide B, may gain widespread relevance to the resulted in ES cells, which maintained the typical colony culture of totipotent ES cells, in vitro differentiation of extra- morphology, however, pluripotent marker genes—Oct4 (Pou5f1), embryonal tissue and organoids, translation to the maintenance of Nanog, Sox2, Zfp42 and others—became down-regulated, at the pluripotent cells of other mammal species, including humans, and same time marker genes of totipotency—particularly Zscan4s and a better molecular understanding of cellular potency in stem cells MERVL—were up-regulated. Zscan4s (Zink finger and SCAN and cancer. domain containing 4) is a transcription factor and MERVL (murine The first successful isolation and maintenance of ES derived endogenous retrovirus L) an endogenous retrovirus with a usually fi 1234567890();,: from the inner cell mass (ICM) of murine blastocyst stages was restricted expression to 2-cell embryos. These results were veri ed described in 1981,2 and since then acted as game changer for by supplementing the culture medium with pladienolide B, a genetic studies in this mammalian model organism.
    [Show full text]
  • Selecting Antagonistic Antibodies That Control Differentiation Through Inducible Expression in Embryonic Stem Cells
    Selecting antagonistic antibodies that control differentiation through inducible expression in embryonic stem cells Anna N. Melidonia,1, Michael R. Dysonb, Sam Wormaldc,2, and John McCaffertya,b,3 aDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom; bIONTAS Ltd., Cambridge CB2 1QW, United Kingdom; and cThe Wellcome Trust Sanger Institute, Hinxton Cambs CB10 1SA, United Kingdom Edited* by Richard A. Lerner, The Scripps Research Institute, La Jolla, CA, and approved August 27, 2013 (received for review June 26, 2013) Antibodies that modulate receptor function have great untapped (5). In an alternative approach, antibodies were retained at the cell potential in the control of stem cell differentiation. In contrast to surface of BaF3 reporter cells, leading to the identification of an many natural ligands, antibodies are stable, exquisitely specific, agonistic antibody to the granulocyte colony-stimulating receptor (6). and are unaffected by the regulatory mechanisms that act on Pluripotent embryonic stem cells (ES cells) represent an ideal natural ligands. Here we describe an innovative system for reporter cell system for identifying functional antibodies because identifying such antibodies by introducing and expressing anti- they are poised to differentiate into many different cell types in body gene populations in ES cells. Following induced antibody vitro (7). ES cell fate decisions are influenced by a wide range of expression and secretion, changes in differentiation outcomes of cell-surface receptors (7–9), creating the potential to target many individual antibody-expressing ES clones are monitored using lin- different classes of ligands and receptors (e.g., receptor tyrosine fi eage-speci c gene expression to identify clones that encode and kinases, G protein-coupled receptors, ion channels, integrins, and express signal-modifying antibodies.
    [Show full text]
  • REX1 Promotes EMT-Induced Cell Metastasis by Activating the JAK2/ STAT3-Signaling Pathway by Targeting SOCS1 in Cervical Cancer
    Oncogene (2019) 38:6940–6957 https://doi.org/10.1038/s41388-019-0906-3 ARTICLE REX1 promotes EMT-induced cell metastasis by activating the JAK2/ STAT3-signaling pathway by targeting SOCS1 in cervical cancer 1 2 1 1,2 Yu-Ting Zeng ● Xiao-Fang Liu ● Wen-Ting Yang ● Peng-Sheng Zheng Received: 15 November 2018 / Revised: 3 July 2019 / Accepted: 5 July 2019 / Published online: 13 August 2019 © The Author(s) 2019. This article is published with open access Abstract ZFP42 zinc finger protein (REX1), a pluripotency marker in mouse pluripotent stem cells, has been identified as a tumor suppressor in several human cancers. However, the function of REX1 in cervical cancer remains unknown. Both IHC and western blot assays demonstrated that the expression of REX1 protein in cervical cancer tissue was much higher than that in normal cervical tissue. A xenograft assay showed that REX1 overexpression in SiHa and HeLa cells facilitated distant metastasis but did not significantly affect tumor formation in vivo. In addition, in vitro cell migration and invasion capabilities were also promoted by REX1. Mechanistically, REX1 overexpression induced epithelial-to-mesenchymal transition (EMT) by upregulating VIMENTIN and downregulating E-CADHERIN. Furthermore, the JAK2/STAT3- 1234567890();,: 1234567890();,: signaling pathway was activated in REX1-overexpressing cells, which also exhibited increased levels of p-STAT3 and p- JAK2, as well as downregulated expression of SOCS1, which is an inhibitor of the JAK2/STAT3-signaling pathway, at both the transcriptional and translational levels. A dual-luciferase reporter assay and qChIP assays confirmed that REX1 trans- suppressed the expression of SOCS1 by binding to two specific regions of the SOCS1 promoter.
    [Show full text]
  • Effect of Long-Term 3D Spheroid Culture on WJ-MSC
    cells Article Effect of Long-Term 3D Spheroid Culture on WJ-MSC Agnieszka Kaminska 1, Aleksandra Wedzinska 1 , Marta Kot 2 and Anna Sarnowska 1,2,* 1 Mossakowski Medical Research Centre, Translational Platform for Regenerative Medicine, Polish Academy of Science, 02-106 Warsaw, Poland; [email protected] (A.K.); [email protected] (A.W.) 2 Mossakowski Medical Research Centre, Department of Stem Cell Bioengineering, Polish Academy of Sciences, 02-106 Warsaw, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-22-6086598 Abstract: The aim of our work was to develop a protocol enabling a derivation of mesenchymal stem/stromal cell (MSC) subpopulation with increased expression of pluripotent and neural genes. For this purpose we used a 3D spheroid culture system optimal for neural stem cells propagation. Although 2D culture conditions are typical and characteristic for MSC, under special treatment these cells can be cultured for a short time in 3D conditions. We examined the effects of prolonged 3D spheroid culture on MSC in hope to select cells with primitive features. Wharton Jelly derived MSC (WJ-MSC) were cultured in 3D neurosphere induction medium for about 20 days in vitro. Then, cells were transported to 2D conditions and confront to the initial population and population constantly cultured in 2D. 3D spheroids culture of WJ-MSC resulted in increased senescence, de- creased stemness and proliferation. However long-termed 3D spheroid culture allowed for selection of cells exhibiting increased expression of early neural and SSEA4 markers what might indicate the survival of cell subpopulation with unique features.
    [Show full text]
  • Vascular Microarray Profiling in Two Models of Hypertension Identifies
    BMC Genomics BioMed Central Research article Open Access Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets T Hilton Grayson1, Stephen J Ohms2, Therese D Brackenbury1, Kate R Meaney1, Kaiman Peng2, Yvonne E Pittelkow3, Susan R Wilson3, Shaun L Sandow4 and Caryl E Hill*1 Address: 1Division of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, Australia, 2Australian Cancer Research Foundation Biomolecular Resource Facility, John Curtin School of Medical Research, Australian National University, Canberra, Australia, 3Centre for Bioinformation Science, Mathematical Sciences Institute, Australian National University, Canberra, Australia and 4School of Medical Sciences, University of New South Wales, Sydney, Australia Email: T Hilton Grayson - [email protected]; Stephen J Ohms - [email protected]; Therese D Brackenbury - [email protected]; Kate R Meaney - [email protected]; Kaiman Peng - [email protected]; Yvonne E Pittelkow - [email protected]; Susan R Wilson - [email protected]; Shaun L Sandow - [email protected]; Caryl E Hill* - [email protected] * Corresponding author Published: 7 November 2007 Received: 27 March 2007 Accepted: 7 November 2007 BMC Genomics 2007, 8:404 doi:10.1186/1471-2164-8-404 This article is available from: http://www.biomedcentral.com/1471-2164/8/404 © 2007 Grayson et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • Tracking the Embryonic Stem Cell Transition from Ground State Pluripotency Tüzer Kalkan1,*, Nelly Olova2, Mila Roode1, Carla Mulas1, Heather J
    © 2017. Published by The Company of Biologists Ltd | Development (2017) 144, 1221-1234 doi:10.1242/dev.142711 STEM CELLS AND REGENERATION TECHNIQUES AND RESOURCES ARTICLE Tracking the embryonic stem cell transition from ground state pluripotency Tüzer Kalkan1,*, Nelly Olova2, Mila Roode1, Carla Mulas1, Heather J. Lee2,3, Isabelle Nett1, Hendrik Marks4, Rachael Walker1,2, Hendrik G. Stunnenberg4, Kathryn S. Lilley5,6, Jennifer Nichols1,7, Wolf Reik2,3,8, Paul Bertone1 and Austin Smith1,5,* ABSTRACT global gene expression is reconfigured and DNA methylation Mouse embryonic stem (ES) cells are locked into self-renewal by increases, which is indicative of a profound cellular transition shielding from inductive cues. Release from this ground state in (Boroviak et al., 2014, 2015; Auclair et al., 2014; Bedzhov and minimal conditions offers a system for delineating developmental Zernicka-Goetz, 2014). Subsequently, egg cylinder epiblast cells are progression from naïve pluripotency. Here, we examine the initial subject to inductive cues leading up to gastrulation and they become transition process. The ES cell population behaves asynchronously. fated, although not yet lineage committed (Tam and Zhou, 1996; We therefore exploited a short-half-life Rex1::GFP reporter to isolate Osorno et al., 2012; Solter et al., 1970). The late phase of ‘ ’ cells either side of exit from naïve status. Extinction of ES cell identity pluripotency during gastrulation is termed primed , reflecting the in single cells is acute. It occurs only after near-complete elimination incipient expression of lineage-specification factors (Nichols and of naïve pluripotency factors, but precedes appearance of lineage Smith, 2009; Hackett and Surani, 2014).
    [Show full text]
  • The Oct4 and Nanog Transcription Network Regulates Pluripotency in Mouse Embryonic Stem Cells
    ARTICLES The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells Yuin-Han Loh1,2,7, Qiang Wu1,7, Joon-Lin Chew1,2,7, Vinsensius B Vega3, Weiwei Zhang1,2, Xi Chen1,2, Guillaume Bourque3, Joshy George3, Bernard Leong3, Jun Liu4, Kee-Yew Wong5, Ken W Sung3, Charlie W H Lee3, Xiao-Dong Zhao4, Kuo-Ping Chiu3, Leonard Lipovich3, Vladimir A Kuznetsov3, Paul Robson2,5, Lawrence W Stanton5, Chia-Lin Wei4, Yijun Ruan4, Bing Lim5,6 & Huck-Hui Ng1,2 Oct4 and Nanog are transcription factors required to maintain the pluripotency and self-renewal of embryonic stem (ES) cells. http://www.nature.com/naturegenetics Using the chromatin immunoprecipitation paired-end ditags method, we mapped the binding sites of these factors in the mouse ES cell genome. We identified 1,083 and 3,006 high-confidence binding sites for Oct4 and Nanog, respectively. Comparative location analyses indicated that Oct4 and Nanog overlap substantially in their targets, and they are bound to genes in different configurations. Using de novo motif discovery algorithms, we defined the cis-acting elements mediating their respective binding to genomic sites. By integrating RNA interference–mediated depletion of Oct4 and Nanog with microarray expression profiling, we demonstrated that these factors can activate or suppress transcription. We further showed that common core downstream targets are important to keep ES cells from differentiating. The emerging picture is one in which Oct4 and Nanog control a cascade of pathways that are intricately connected to govern pluripotency, self-renewal, genome surveillance and cell fate determination. Nature Publishing Group Group Nature Publishing 6 ES cells are pluripotent cells derived from the inner cell mass (ICM) protein, was identified as a factor that can sustain pluripotency 200 of the mammalian blastocyst.
    [Show full text]
  • A Prominent and Conserved Role for YY1 in Xist Transcriptional Activation
    ARTICLE Received 4 Feb 2014 | Accepted 1 Aug 2014 | Published 11 Sep 2014 DOI: 10.1038/ncomms5878 A prominent and conserved role for YY1 in Xist transcriptional activation Me´lanie Makhlouf1,2,*, Jean-Franc¸ois Ouimette1,2,*, Andrew Oldfield1,2,*,w, Pablo Navarro3, Damien Neuillet1,2 & Claire Rougeulle1,2 Accumulation of the noncoding RNA Xist on one X chromosome in female cells is a hallmark of X-chromosome inactivation (XCI) in eutherians. Here we uncover an essential function for the ubiquitous autosomal transcription factor Yin-Yang 1 (YY1) in the transcriptional acti- vation of Xist in both human and mouse. We show that loss of YY1 prevents Xist upregulation during the initiation and maintenance of X-inactivation, and that YY1 binds directly the Xist 50 region to trigger the activity of the Xist promoter. Binding of YY1 to the Xist 50 region before XCI competes with the Xist repressor REX1, whereas DNA methylation controls mono-allelic fixation of YY1 to Xist at the onset of XCI. YY1 is thus the first autosomal activating factor involved in a fundamental and conserved pathway of Xist regulation that ensures the asymmetric transcriptional upregulation of the master regulator of XCI. 1 CNRS, UMR7216 Epigenetics and Cell Fate, F-75013 Paris, France. 2 Univ Paris Diderot, Sorbonne Paris Cite´, F-75013 Paris, France. 3 CNRS, URA2578 Institute Pasteur, 75015 Paris, France. * These authors contributed equally to this work. wPresent address: NIEHS, Laboratory of Molecular Carcinogenesis, Systems Biology, Research Triangle Park, North Carolina 27709, USA. Correspondence and requests for materials should be addressed to C.R.
    [Show full text]
  • Demarcation of Stable Subpopulations Within the Pluripotent Hesc Compartment
    Demarcation of Stable Subpopulations within the Pluripotent hESC Compartment Sonam Bhatia1,3, Carlos Pilquil1, Ivana Roth-Albin1, Jonathan S. Draper1,2,3* 1 McMaster Stem Cell and Cancer Research Institute, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada, 2 Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada, 3 Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada Abstract Heterogeneity is a feature of stem cell populations, resulting from innate cellular hierarchies that govern differentiation capability. How heterogeneity impacts human pluripotent stem cell populations is directly relevant to their efficacious use in regenerative medicine applications. The control of pluripotency is asserted by a core transcription factor network, of which Oct4 is a necessary member. In mouse embryonic stem cells (ESCs), the zinc finger transcription factor Rex1 (Zfp42) closely tracks the undifferentiated state and is capable of segregating Oct4 positive mESCs into metastable populations expressing or lacking Rex1 that are inter-convertible. However, little is currently understood about the extent or function of heterogeneous populations in the human pluripotent compartment. Human ESCs express REX1 transcripts but the distribution and properties of REX1 expressing cells have yet to be described. To address these questions, we used gene targeting in human ESCs to insert the fluorescent protein Venus and an antibiotic selection marker under the control of the endogenous REX1 transcription regulatory elements, generating a sensitive, selectable reporter of pluripotency. REX1 is co- expressed in OCT4 and TRA-1-60 positive hESCs and rapidly lost upon differentiation. Importantly, REX1 expression reveals significant heterogeneity within seemingly homogenous populations of OCT4 and TRA-1-60 hESCs.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,970,552 B1
    US007970552B1 (12) United States Patent (10) Patent No.: US 7,970,552 B1 Stefanon et al. 45) Date of Patent: Jun. 28,9 2011 (54) DIAGNOSTIC SYSTEM FOR SELECTING 3. R 238, E. 1 NUTRITION AND PHARMACOLOGICAL 6,493,641- - w B1 12/2002 Singheblak et et al. al. PRODUCTS FOR ANIMALS 6,537,213 B2 3/2003 Dodds 6,730,023 B1 5, 2004 Dodds (76) Inventors: Bruno Stefanon, Martignacco (IT): W. 7,029.441 B2 4/2006 Dodds Jean Dodds, Santa Monica, CA (US) 7,296,5377,134,995 B2 12/200611/2006 BurghardiDodds et al. (*) Notice: Subject to any disclaimer, the term of this (Continued) patent is extended or adjusted under 35 U.S.C. 154(b) by 0 days. FOREIGN PATENT DOCUMENTS WO WO99-67642 A2 12/1999 (21) Appl. No.: 12/927,769 (Continued) (22) Filed: Nov. 19, 2010 OTHER PUBLICATIONS Related U.S. Application Data Swanson et al., “Nutritional Genomics: Implication for Companion Animals'. The American Society for Nutritional Sciences, (2003).J. (63) Continuation of application No. 12/316,824, filed on Nutr. 133:3033-3040 (18 pages). Dec. 16, 2008, now Pat. No. 7,873,482. (Continued) (51) Int. Cl. G06F 9/00 (2006.01) Primary Examiner — Edward Raymond (52) U.S. Cl. ......................................................... 702/19 (74) Attorney, Agent, or Firm — Greenberg Traurig, LLP 58) Field of Classification Search .................... 702/19, (58) 702/182 185 (57) ABSTRACT See application file for complete search history. An analysis of the profile of a non-human animal comprises: a) providing a genotypic database to the species of the non (56) References Cited human animal Subject or a selected group of the species; b) obtaining animal data; c) correlating the database of a) with U.S.
    [Show full text]
  • Somatostatin Receptor Type 2 Contributes to the Self-Renewal of Murine Embryonic Stem Cells
    Acta Pharmacologica Sinica (2014) 35: 1023–1030 npg © 2014 CPS and SIMM All rights reserved 1671-4083/14 $32.00 www.nature.com/aps Original Article Somatostatin receptor type 2 contributes to the self-renewal of murine embryonic stem cells Xin-xiu XU1, 2, Li-hong ZHANG1, *, Xin XIE1, 2, * 1CAS Key Laboratory of Receptor Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; 2Shanghai Key Laboratory of Signaling and Disease Research, Laboratory of Receptor-based Bio-medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China Aim: The roles of G-protein coupled receptors (GPCRs) in stem cell biology remain unclear. In this study, we aimed to identify GPCRs that might contribute to the self-renewal of mouse embryonic stem cells (mESCs). Methods: The expression levels of pluripotent genes and GPCR gene were detected in E14 mESCs using PCR array and RT-PCR. Immunofluorescent staining was used to examine the expression of pluripotent markers and the receptor translocation. Western blot analysis was used to detect phosphorylation of signal proteins. Knock-down of receptor was conducted to confirm its role in pluripotency maintenance. Results: In leukemia inhibitory factor (LIF)-free medium, mESCs lost the typical morphology of pluripotency, accompanied by markedly decreases in expression of somatostatin receptor type 2 (SSTR2), as well as the pluripotency biomarkers Oct4, Sox2, Rex1 and Nanog. Addition of the SSTR2 agonist octreotide or seglitide (0.1–30 μmol/L) in LIF-free medium dose-dependently promoted the self-renewal of mESCs, whereas the SSTR2 antagonist S4 (0.03–3 μmol/L) dose-dependently blocked octreotide-induced self-renewal.
    [Show full text]